News

Sage Therapeutics: Biogen's $7.22/Share Bid Might Say More Than The Price Tag
Biogen's $7.22 per share buyout offer signals confidence in Sage's commercial potential and drug pipeline. Read why SAGE ...
Hosted on MSN22d
PDD Holdings Inc. (NASDAQ:PDD): Among the Best Chinese Stocks to Buy According to Billionaires
Logistics support measures helped PPD grow a double-digit order volume in remote regions, expanding free shipping to almost 100 million consumers. PDD Holdings Inc. continues to invest in ...